The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis

R Amaro, M Panagiotarakou, V Alcaraz… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic
pulmonary disease, characterized by the permanent and abnormal enlargement and …

The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis

R Amaro, M Panagiotaraka… - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic pulmonary
disease, characterized by the permanent and abnormal enlargement and thickening of …

[PDF][PDF] The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis

R Amaro, M Panagiotaraka, V Alcaraz, A Torres - 2018 - researchgate.net
Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic
pulmonary disease, characterized by the permanent and abnormal enlargement and …

The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis

R Amaro, M Panagiotaraka, V Alcaraz… - Expert Review of …, 2018 - merit.url.edu
Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic
pulmonary disease, characterized by the permanent and abnormal enlargement and …

The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.

R Amaro, M Panagiotaraka, V Alcaraz… - Expert Review of …, 2018 - europepmc.org
Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic pulmonary
disease, characterized by the permanent and abnormal enlargement and thickening of …

The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis

R Amaro, M Panagiotaraka, V Alcaraz… - Expert Review of …, 2018 - merit.url.edu
Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic
pulmonary disease, characterized by the permanent and abnormal enlargement and …